|
|
||||||||
REPORT
enhances cardiac contractility and protects against infarction-induced heart failure1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, and 2Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio
Submitted 23 April 2007 ; accepted in final form 1 October 2007
Mice null for the gene encoding protein kinase C
(Prkca), or mice treated with pharmacologic inhibitors of the PKC
/β/
isoforms, show an augmentation in cardiac contractility that appears to be cardioprotective. However, it remains uncertain if PKC
itself functions in a myocyte autonomous manner to affect cardioprotection in vivo. Here we generated cardiac myocyte-specific transgenic mice using a tetracycline-inducible system to permit controlled expression of dominant negative PKC
in the heart. Consistent with the proposed function of PKC
, induction of dominant negative PKC
expression in the adult heart enhanced baseline cardiac contractility. This increase in cardiac contractility was associated with a partial protection from long-term decompensation and secondary dilated cardiomyopathy after myocardial infarction injury. Similarly, Prkca null mice were also partially protected from infarction-induced heart failure, although the area of infarction injury was identical to controls. Thus, myocyte autonomous inhibition of PKC
protects the adult heart from decompensation and dilated cardiomyopathy after infarction injury in association with a primary enhancement in contractility.
protein kinase C; signaling; myocardial infarction
This article has been cited by other articles:
![]() |
T. Koyanagi, L. Y. Wong, K. Inagaki, O. V. Petrauskene, and D. Mochly-Rosen Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H220 - H226. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |